Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Zalcberg, JR
Bishop, JF
Millward, MJ
Zimet, A
Laird, J
Barter, C
Seward, D
McKeage, MJ
Friedlander, ML
Toner, G
Berille, J
Blanc, C
机构：
[1] HEIDELBERG REPATRIAT HOSP,DEPT ONCOL,MELBOURNE,VIC 3081,AUSTRALIA
[2] HEIDELBERG REPATRIAT HOSP,DEPT THORAC MED,MELBOURNE,VIC 3081,AUSTRALIA
[3] PETER MACCALLUM CANC INST,DIV HAEMATOL & MED ONCOL,MELBOURNE,VIC 3002,AUSTRALIA
[4] PRINCE WALES HOSP,INST ONCOL,SYDNEY,NSW 2031,AUSTRALIA
[5] RHONE POULENC RORER,ANTONY,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1084 / 1084
页数：1
相关论文
共 50 条
  • [21] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: results of a multicentre randomized phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaeper, C.
    Temmesfeld-Wollbrueck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 143 - 150
  • [22] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
  • [23] A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
    Kunitoh, H
    Akiyama, Y
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Ohe, Y
    Kubota, K
    Tamura, T
    Shinkai, T
    Kodama, T
    Goto, K
    Niho, S
    Nishiwaki, Y
    Saijo, N
    [J]. LUNG CANCER, 2001, 33 (2-3) : 259 - 265
  • [24] Sequential cisplatin-gemcitabine-docetaxel vs docetaxel-gemcitabine in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Interim results of an ongoing phase II trial.
    Binder, D
    Beinert, T
    Schweisfurth, H
    Grah, C
    Temmesfeld-Wollbrock, B
    Müller-Hagen, G
    Schäper, C
    Schürmann, D
    Suttorp, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 644S - 644S
  • [25] Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Barata, Fernando
    Sousa, Amelia
    Camacho, Elvira
    Costa, Marco S.
    Canario, Dolores
    Nogueira, Fernando
    Semedo, Eulalia
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 179 - 179
  • [26] A phase II trial of zoledronic acid in combination with cisplatin and docetaxel in non-small cell lung cancer patients with bone metastases
    Yoh, K.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Naito, Y.
    Ohe, Y.
    Saijo, N.
    Nishiwaki, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Indisulam (E7070) in combination with carboplatin in patients with locally advanced/metastatic non-small cell lung cancer (NSCLC) - A phase II study
    Hermes, A
    Reck, M
    Dittrich, C
    O'Brien, M
    Derigs, H
    Johnston, C
    Berns, B
    Gatzemeier, U
    [J]. LUNG CANCER, 2005, 49 : S247 - S247
  • [28] Interim results of a sequential administration of docetaxel (TAXOTERE(R)) followed by cisplatin-vindesine in chemotherapy naive patients with locally advanced or metastatic non small cell lung cancer (NSCLC)
    Antoine, EC
    Orcel, B
    Benhammouda, A
    Vannetzel, JM
    Lenseigne, S
    SoussanLazard, K
    Loret, C
    Berille, J
    Derenne, JP
    Khayat, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1085 - 1085
  • [29] A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaive patients with metastatic or locally advanced non-small cell lung cancer
    Ho, JCM
    Tan, EH
    Leong, SS
    Wang, CH
    Sun, Y
    Li, R
    Wahid, MIA
    Jusuf, A
    Liao, M
    Guan, Z
    Handoyo, P
    Huang, JS
    Chan, V
    Luna, G
    Tsang, KWT
    Lam, WK
    [J]. RESPIRATORY MEDICINE, 2003, 97 (07) : 796 - 803
  • [30] PHASE II TRIAL OF IMATINIB MESYLATE AND DOCETAXEL IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER
    Papadimitrakopoulou, Vassiliki
    Liu, Suyu
    Fujimoto, Junya
    Wistuba, Ignacio
    Lee, J. J.
    Marom, Edith M.
    Charnsangavej, Chusilp
    Fossella, Frank V.
    Tran, Hai T.
    Blumenschein, George
    Kies, Merrill
    Hong, Waun K.
    Stewart, David J.
    Tsao, Anne
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1235 - S1235
12345